Explores a unified framework for understanding and evaluating generative sequence models of DNA/RNA or Protein, covering topics like coevolution, conservation, and different models such as GREMLIN and BERT.
Explores the selection and rationale of preclinical animal models in drug development, emphasizing the 10 to 15-year path to a marketed small-molecule drug.
